ClinConnect ClinConnect Logo
Search / Trial NCT03195582

The Effect of Chlorohexidine Gel on Tissue Healing Following Surgical Exposure of Dental Implants

Launched by RAMBAM HEALTH CARE CAMPUS · Jun 21, 2017

Trial Information

Current as of June 16, 2025

Unknown status

Keywords

ClinConnect Summary

Patients who received implants in our department, and scheduled for surgical uncovering of the implants will be asked to participate in this clinical trial (40) Patients from Department of periodontology, Rambam Health campus, Haifa in Israel will be recruited to Randomized clinical trial; patients will be divided randomly in to 2 groups:

1. Control: following uncovering of the implant a 4 mm height healing abutment will be screwed to the implant (the standard treatment modality) without using Chlorohexidine gel or any other gel.
2. Test group: following implant exposure this group will re...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients who are willing to participate and willing to provide an informed consent.
  • 2. Males and females between the ages 18-80
  • 3. In good general health.
  • 4. Patients who received dental implants and require implant uncovering (if there is more than 1 implant, a minimum radiographic distance of 3 mm will be required between implants).
  • Exclusion Criteria:
  • 1. Uncontrolled Type 1 or type 2 diabetes patients( HbA1C\>7).
  • 2. Subjects treated for at least 2 weeks with any medication known to affect soft tissue condition within one month prior to baseline examination (e.g., Phenytoin, Cyclosporine, and chronic use of Bisphosphonates).
  • 3. Patients who underwent guided bone regeneration during implant placement.
  • 4. Patients who used antibiotic during the study or 4 weeks prior to the baseline.
  • 5. Active periodontitis patients.
  • 6. Subjects with presence of active systemic infectious diseases such as: Hepatitis, HIV, history of tuberculosis.
  • 7. Pregnant or lactating females.

About Rambam Health Care Campus

Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.

Locations

Patients applied

0 patients applied

Trial Officials

Hadar Zigdon, Dr.

Principal Investigator

Rambam Health Care Campus

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials